Last updated at 04 Jul 2024 02:52 AM
Director
DIN: 08065529
Mandeep Singh Bhamra is currently associated with 2 companies as Director. They serve as a Director at RAVENBHEL HEALTH CARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08065529.Mandeep Singh Bhamra has previously been associated with 2 companies in roles such as Additional Director.Mandeep Singh Bhamra is currently involved in 1 different role. Their most recent position is with SALUTEM PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Mandeep Singh Bhamra was appointed to as a director was RAVENBHEL HEALTH CARE PRIVATE LIMITED. Mandeep Singh Bhamra is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mandeep Singh Bhamra is currently associated with 2 companies as Director. They serve as a Director at RAVENBHEL HEALTH CARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08065529.Mandeep Singh Bhamra has previously been associated with 2 companies in roles such as Additional Director.Mandeep Singh Bhamra is currently involved in 1 different role. Their most recent position is with SALUTEM PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Mandeep Singh Bhamra was appointed to as a director was RAVENBHEL HEALTH CARE PRIVATE LIMITED. Mandeep Singh Bhamra is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
1y 7m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| RAVENBHEL HEALTH CARE PRIVATE LIMITED | Director | 29-Sep-2018 |
| SALUTEM PHARMACEUTICALS PRIVATE LIMITED | Director | 30-Nov-2021 |